Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2018, Article ID 7465794, 10 pages
https://doi.org/10.1155/2018/7465794
Clinical Study

Subthreshold Photocoagulation Using Endpoint Management in the PASCAL® System for Diffuse Diabetic Macular Edema

1Department of Ophthalmology, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan
2Department of Ophthalmology, St. Luke’s International Hospital, 9-1 Akashi-cho, Chuo-ku, Tokyo 104-8560, Japan
3Department of Ophthalmology, Juntendo University Urayasu Hospital, 1-1 Tomioka 2-chome, Urayasu-shi, Chiba 279-0021, Japan

Correspondence should be addressed to Masafumi Hamada; pj.ca.ekul@asamamah

Received 5 October 2017; Accepted 11 December 2017; Published 31 January 2018

Academic Editor: Toshihide Kurihara

Copyright © 2018 Masafumi Hamada et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Diabetes. Fact sheet No. 312, December 2009, http://www.who.int/mediacentre/factsheets/fs312/en/.
  2. R. Klein, “Retinopathy in a population-based study,” Transactions of the American Ophthalmological Society, vol. 90, pp. 561–594, 1992. View at Google Scholar
  3. R. Klein and B. E. Klein, “Vision disorders in diabetes,” in Diabetes in America, National Institutes of Health, Bethesda, MD, 2nd edition, 1995. View at Google Scholar
  4. Early Treatment Diabetic Retinopathy Study research group, “Photocoagulation for diabetic macular edema: early treatment diabetic retinopathy study report number 1,” Archives of Ophthalmology, vol. 103, no. 12, pp. 1796–1806, 1985. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Schatz, D. Madeira, H. R. McDonald, and R. N. Johnson, “Progressive enlargement of laser scars following grid laser photocoagulation for diffuse diabetic macular edema,” Archives of Ophthalmology, vol. 109, no. 11, pp. 1549–1551, 1991. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Roider, “Laser treatment of retinal diseases by subthreshold laser effects,” Seminars in Ophthalmology, vol. 14, no. 1, pp. 19–26, 1999. View at Publisher · View at Google Scholar
  7. K. Maeshima, N. Utsugi-Sutoh, T. Otani, and S. Kishi, “Progressive enlargement of scattered photocoagulation scars in diabetic retinopathy,” Retina, vol. 24, no. 4, pp. 507–511, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. J. W. Berger, “Thermal modelling of micropulsed diode laser retinal photocoagulation,” Lasers in Surgery and Medicine, vol. 20, no. 4, pp. 409–415, 1997. View at Publisher · View at Google Scholar
  9. P. E. Stanga, A. C. Reck, and A. M. P. Hamilton, “Micropulse laser in the treatment of diabetic macular edema,” Seminars in Ophthalmology, vol. 14, no. 4, pp. 210–213, 1999. View at Publisher · View at Google Scholar
  10. S. Vujosevic, E. Bottega, M. Casciano, E. Pilotto, E. Convento, and E. Midena, “Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation,” Retina, vol. 30, no. 6, pp. 908–916, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. T. R. Friberg and E. C. Karatza, “The treatment of macular disease using a micropulsed and continuous wave 810-nm diode laser,” Ophthalmology, vol. 104, no. 12, pp. 2030–2038, 1997. View at Publisher · View at Google Scholar
  12. Y. Hoshikawa, K. Ohkoshi, and T. Yamaguchi, “Retinal sensitivity following subthreshold diode laser micropulse photocoagulation for diabetic macular edema,” Nippon Ganka Gakkai Zasshi, vol. 115, no. 1, pp. 13–19, 2011. View at Google Scholar
  13. K. Inagaki, T. Shuo, K. Katakura, N. Ebihara, A. Murakami, and K. Ohkoshi, “Sublethal photothermal stimulation with a micropulse laser induces heat shock protein expression in ARPE-19 cells,” Journal of Ophthalmology, vol. 2015, Article ID 729792, 9 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. M. M. Muqit, J. Denniss, V. Nourrit et al., “Spatial and spectral imaging of retinal laser photocoagulation burns,” Investigative Ophthalmology & Visual Science, vol. 52, no. 2, pp. 994–1002, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Latalska, A. Prokopiuk, A. Wrzawa, and A. Yoshida, “Short-term effects of intravitreal ranibizumab therapy on diabetic macular edema.n for diabetic macular oedema treated with ranibizumab,” British Journal of Ophthalmolabetic Retinopathy, vol. 24, no. 1, pp. 96–99, 2017. View at Google Scholar
  16. F. Fazel, M. Bagheri, K. Golabchi, and H. Jahanbani Ardakani, “Comparison of subthreshold diode laser micropulse therapy versus conventional photocoagulation laser therapy as primary treatment of diabetic macular edema,” Journal of Current Ophthalmology, vol. 28, no. 4, pp. 206–211, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Chen, R. Tzekov, W. Li, F. Jiang, S. Mao, and Y. Tong, “Subthreshold micropulse diode laser versus conventional laser photocoagulation for diabetic macular edema: a meta-analysis of randomized controlled trials,” Retina, vol. 36, no. 11, pp. 2059–2065, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Vujosevic, F. Martini, E. Longhin, E. Convento, F. Cavarzeran, and E. Midena, “Subthreshold micropulse yellow laser versus subthreshold micropulse infrared laser in center-involving diabetic macular edema: morphologic and functional safety,” Retina, vol. 35, no. 8, pp. 1594–1603, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Lavinsky, C. Sramek, J. Wang et al., “Subvisible retinal laser therapy: titration algorithm and tissue response,” Retina, vol. 34, no. 1, pp. 87–97, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. W. Pei-pei, H. Shi-zhou, T. Zhen et al., “Randomised clinical trial evaluating best-corrected visual acuity and central macular thickness after 532-nm subthreshold laser grid photocoagulation treatment in diabetic macular oedema,” Eye, vol. 29, no. 3, pp. 313–322, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. World Health Organization, Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Report of a WHO Consultation, World Health Organization, Geneva, 1999.
  22. B. W. Jones, P. Huie, H. Wang, A. Sher, R. E. Marc, and D. Palanker, “Neural activity in the inner retina after photocoagulation,” Investigative Ophthalmology & Visual Science, vol. 52, p. 1170, 2011. View at Google Scholar
  23. J. T. Beckham, G. J. Wilmink, M. A. Mackanos et al., “Role of HSP70 in cellular thermotolerance,” Lasers in Surgery and Medicine, vol. 40, no. 10, pp. 704–715, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Du, Q. Zhang, S. Zhang, L. Wang, and J. Lian, “Heat shock protein 70 expression induced by diode laser irradiation onchoroid-retinal endothelial cells in vitro,” Molecular Vision, vol. 18, pp. 2380–2387, 2012. View at Google Scholar
  25. D. Lanneau, A. deThonel, S. Maurel, C. Didelot, and C. Garrido, “Apoptosis versus cell differentiation: role of heat shock proteins HSP90, HSP70 and HSP27,” Prion, vol. 1, no. 1, pp. 53–60, 2007. View at Publisher · View at Google Scholar
  26. M. N. Rylander, Y. Feng, J. Bass, and K. R. Diller, “Thermally induced injury and heat-shock protein expression in cells and tissues,” Annals of the New York Academy of Sciences, vol. 1066, no. 1, pp. 222–242, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Sõti, E. Nagy, Z. Giricz, L. Vígh, P. Csermely, and P. Ferdinandy, “Heat shock proteins as emerging therapeutic targets,” British Journal of Pharmacology, vol. 146, no. 6, pp. 769–780, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. M. A. Yenari, J. Liu, Z. Zheng, Z. S. Vexler, J. E. Lee, and R. G. Giffard, “Antiapoptotic and anti-inflammatory mechanisms of heat-shock protein protection,” Annals of the New York Academy of Sciences, vol. 1053, no. 1, pp. 74–83, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. M. J. Elman, A. Ayala, N. M. Bressler et al., “Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results,” Ophthalmology, vol. 122, no. 2, pp. 375–381, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. Q. D. Nguyen, D. M. Brown, D. M. Marcus et al., “Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE,” Ophthalmology, vol. 119, no. 4, pp. 789–801, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. D. S. Boyer, Q. D. Nguyen, D. M. Brown, K. Basu, J. S. Ehrlich, and RIDE and RISE Research Group, “Outcomes with as-needed ranibizumab after initial monthly therapy: long-term outcomes of the phase III RIDE and RISE trials,” Ophthalmology, vol. 122, no. 12, pp. 2504–2513.e1, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. Q. D. Nguyen, S. M. Shah, J. S. Heier et al., “Primary end point (six months) results of the ranibizumab for edema of the macula in diabetes (READ-2) study,” Ophthalmology, vol. 116, no. 11, pp. 2175–2181.e1, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. Q. D. Nguyen, S. M. Shah, A. A. Khwaja et al., “Two-year outcomes of the ranibizumab for edema of the macula in diabetes (READ-2) study,” Ophthalmology, vol. 117, no. 11, pp. 2146–2151, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Massin, F. Bandello, J. G. Garweg et al., “Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE study): a 12-month, randomized, controlled, double-masked, multicenter phase II study,” Diabetes Care, vol. 33, no. 11, pp. 2399–2405, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Mitchell, F. Bandello, U. Schmidt-Erfurth et al., “The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema,” Ophthalmology, vol. 118, no. 4, pp. 615–625, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. U. Schmidt-Erfurth, G. E. Lang, F. G. Holz et al., “Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE extension study,” Ophthalmology, vol. 121, no. 5, pp. 1045–1053, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Ishibashi, X. Li, A. Koh et al., “The REVEAL study: ranibizumab monotherapy or combined with laser versus laser monotherapy in Asian patients with diabetic macular edema,” Ophthalmology, vol. 122, no. 7, pp. 1402–1415, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. D. E. Welch, H. Elmariah, M. C. Peden, S. G. Adams, R. Ratnakaram, and S. Kaushal, “Short-term response of macular oedema to intravitreal bevacizumab,” The British Journal of Ophthalmology, vol. 93, no. 8, pp. 1033–1036, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. P. A. Karth, A. Chang, and W. Wirostko, “Paired responses to intravitreal bevacizumab in diabetic macular edema,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 252, no. 2, pp. 207–211, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. R. Sophie, N. Lu, and P. A. Campochiaro, “Predictors of functional and anatomic outcomes in patients with diabetic macular edema treated with ranibizumab,” Ophthalmology, vol. 122, no. 7, pp. 1395–1401, 2015. View at Publisher · View at Google Scholar · View at Scopus
  41. S. B. Bressler, H. Qin, R. W. Beck et al., “Factors associated with changes in visual acuity and central subfield thickness at 1 year after treatment for diabetic macular edema with ranibizumab,” Archives of Ophthalmology, vol. 130, no. 9, pp. 1153–1161, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Ebneter, S. Wolf, and M. S. Zinkernagel, “Prognostic significance of foveal capillary drop-out and previous panretinal photocoagulation for diabetic macular oedema treated with ranibizumab,” The British Journal of Ophthalmology, vol. 100, no. 3, pp. 365–370, 2016. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Minami, T. Nagaoka, A. Ishibazawa, and A. Yoshida, “Short-term effects of intravitreal ranibizumab therapy on diabetic macular edema,” BMC Ophthalmology, vol. 17, no. 1, p. 28, 2017. View at Publisher · View at Google Scholar · View at Scopus